Sequence analysis identified IDH1 R132H mutations in six of 40 (20 %) assessed brain tumors, namely in two oligodendrogliomas grade II, one oligodendroglioma grade III, two astrocytomas grade II, and one GBM. The gene discussed is IDH1; the disease is oligodendroglioma.